Norton C R, Rumberger J M, Burns D K, Wolitzky B A
Department of Inflammation/Autoimmune Diseases, Hoffmann-La Roche Inc., Nutley, N.J. 07110.
Biochem Biophys Res Commun. 1993 Aug 31;195(1):250-8. doi: 10.1006/bbrc.1993.2037.
A recombinant phage containing the structural exons for mouse E-selectin has been isolated and characterized. Utilizing PCR techniques the lectin and egf domains were fused to form an artificial cDNA for expression in eukaryotic cells. Transient expression in COS cells demonstrated the lectin and egf domains were sufficient to mediate the binding of mouse and human neutrophils as well as HL60 cells. Recombinant soluble mouse E-selectin was purified and used to immunize rats to generate mAbs specific to mouse E-selectin. A panel of mAbs directed against mouse E-selectin was characterized including five that inhibit the adhesion of HL60 cells or mouse neutrophils to COS cells expressing the mouse lectin/egf domains. These mAbs have been used to characterize the expression and function of E-selectin on cytokine stimulated eEnd.2 murine endothelial cells.
一种含有小鼠E-选择素结构外显子的重组噬菌体已被分离和鉴定。利用PCR技术将凝集素和表皮生长因子(EGF)结构域融合,形成用于在真核细胞中表达的人工cDNA。在COS细胞中的瞬时表达表明,凝集素和EGF结构域足以介导小鼠和人类中性粒细胞以及HL60细胞的结合。重组可溶性小鼠E-选择素被纯化,并用于免疫大鼠以产生对小鼠E-选择素特异的单克隆抗体(mAb)。一组针对小鼠E-选择素的mAb被鉴定,其中五种可抑制HL60细胞或小鼠中性粒细胞与表达小鼠凝集素/EGF结构域的COS细胞的粘附。这些mAb已被用于表征E-选择素在细胞因子刺激的eEnd.2小鼠内皮细胞上的表达和功能。